Concepts (76)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 4 | 2021 | 233 | 1.030 |
Why?
|
| Phantom Limb | 3 | 2020 | 9 | 1.020 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 117 | 0.860 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 801 | 0.540 |
Why?
|
| Thrombolytic Therapy | 2 | 2024 | 36 | 0.470 |
Why?
|
| Fibrinolytic Agents | 2 | 2024 | 67 | 0.460 |
Why?
|
| Motor Cortex | 2 | 2020 | 45 | 0.350 |
Why?
|
| Cerebral Hemorrhage | 2 | 2021 | 90 | 0.350 |
Why?
|
| Intracranial Hemorrhages | 3 | 2024 | 30 | 0.280 |
Why?
|
| Retrospective Studies | 6 | 2024 | 2429 | 0.280 |
Why?
|
| Middle Aged | 9 | 2024 | 6812 | 0.250 |
Why?
|
| Vertebral Artery Dissection | 1 | 2024 | 4 | 0.240 |
Why?
|
| Disability Evaluation | 1 | 2024 | 54 | 0.240 |
Why?
|
| Recovery of Function | 1 | 2024 | 111 | 0.230 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 472 | 0.210 |
Why?
|
| Amputees | 2 | 2020 | 7 | 0.210 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 747 | 0.210 |
Why?
|
| Neurovascular Coupling | 1 | 2024 | 152 | 0.200 |
Why?
|
| Humans | 12 | 2024 | 26827 | 0.190 |
Why?
|
| Diagnostic Errors | 1 | 2021 | 33 | 0.190 |
Why?
|
| Male | 9 | 2024 | 12867 | 0.190 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 259 | 0.180 |
Why?
|
| Cortical Excitability | 1 | 2020 | 2 | 0.180 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 16 | 0.180 |
Why?
|
| Gray Matter | 1 | 2020 | 23 | 0.180 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 37 | 0.180 |
Why?
|
| Secondary Prevention | 1 | 2020 | 44 | 0.180 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 25 | 0.180 |
Why?
|
| Functional Laterality | 1 | 2020 | 62 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2020 | 60 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 47 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 51 | 0.170 |
Why?
|
| Brain Ischemia | 1 | 2020 | 80 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2020 | 82 | 0.170 |
Why?
|
| Aspirin | 1 | 2020 | 119 | 0.170 |
Why?
|
| Video Recording | 1 | 2019 | 38 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 187 | 0.160 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2017 | 12 | 0.140 |
Why?
|
| Female | 9 | 2024 | 14455 | 0.140 |
Why?
|
| Spinal Cord Injuries | 1 | 2017 | 55 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 110 | 0.130 |
Why?
|
| Administration, Intravenous | 2 | 2024 | 25 | 0.120 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 910 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2024 | 36 | 0.120 |
Why?
|
| Time Factors | 3 | 2024 | 1563 | 0.110 |
Why?
|
| Aged | 4 | 2024 | 5158 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2024 | 2262 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 7380 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 399 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 1924 | 0.070 |
Why?
|
| Risk Factors | 2 | 2020 | 2006 | 0.060 |
Why?
|
| Illinois | 1 | 2024 | 3 | 0.060 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2024 | 2 | 0.060 |
Why?
|
| Rural Health Services | 1 | 2024 | 22 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2024 | 49 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2024 | 72 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 305 | 0.050 |
Why?
|
| Young Adult | 2 | 2020 | 2580 | 0.050 |
Why?
|
| Chicago | 1 | 2020 | 6 | 0.050 |
Why?
|
| Hematoma | 1 | 2020 | 26 | 0.050 |
Why?
|
| Sensorimotor Cortex | 1 | 2020 | 7 | 0.050 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2020 | 11 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 19 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 49 | 0.040 |
Why?
|
| Amputation | 1 | 2020 | 42 | 0.040 |
Why?
|
| Length of Stay | 1 | 2021 | 215 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 315 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 252 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 165 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 444 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2020 | 198 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 586 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 759 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 125 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 388 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 374 | 0.030 |
Why?
|